MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KUN, E.
Right arrow Articles by LOH, H. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KUN, E.
Right arrow Articles by LOH, H. H.

Molecular Pharmacology, Vol 3, 497-502, Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics

Studies with Specific Enzyme Inhibitors

XI. Identification of Tissue-Specific Metabolic Organization of Mitochondria by Monofluorocitrate

ERNEST KUN 1, PIERRE VOLFIN 1, and HORACE H. LOH 1

1 Departments of Pharmacology and Biochemistry and the Cardiovascular Research Institute, University of California, School of Medicine, San Francisco, California 94122

Rates of O2 uptake of mitochondria vary depending on the nature of added substrate, on assay conditions, and on the tissue from which mitochondria are isolated. Inhibition of aconitase by fluorocitrate influenced O2 uptake and citrate accumulation in a highly selective manner. Metabolic effectivity of fluorocitrate was dependent on the same variables which determine specific metabolic rates in the absence of the inhibitor. It is proposed that the experimental design applied detects metabolic consequences of tissue-specific control mechanisms.

Note:
ACKNOWLEDGMENTS The work reported in this paper was supported by research grants of the U.S. Public Health Service (RO1-HD-01239-11 and RO1-CA-07955-03), the National Science Foundation (GB-5749), and the American Heart Association, Inc. (66-652).

Submitted on April 14, 1967







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics